A Survey of Canadian Nephrologists Assessing Prognostication in End-Stage Renal Disease.

Autor: Forzley B; Department of Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.; Interior Health Authority, Kelowna, British Columbia, Canada., Chiu HHL; BC Provincial Renal Agency, Vancouver, British Columbia, Canada., Djurdjev O; BC Provincial Renal Agency, Vancouver, British Columbia, Canada., Carson RC; Department of Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.; Island Health Authority, Victoria, British Columbia, Canada., Hargrove G; Department of Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.; Island Health Authority, Victoria, British Columbia, Canada., Martinusen D; Island Health Authority, Victoria, British Columbia, Canada.; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada., Karim M; Department of Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.; Fraser Health Authority, Surrey, British Columbia, Canada.
Jazyk: angličtina
Zdroj: Canadian journal of kidney health and disease [Can J Kidney Health Dis] 2017 Aug 18; Vol. 4, pp. 2054358117725294. Date of Electronic Publication: 2017 Aug 18 (Print Publication: 2017).
DOI: 10.1177/2054358117725294
Abstrakt: Background: Patients with end-stage renal disease (ESRD) frequently have a relatively poor prognosis with complex care needs that depend on prognosis. While many means of assessing prognosis are available, little is known about how Canadian nephrologists predict prognosis, whether they routinely share prognostic information with their patients, and how this information guides management.
Objective: To guide improvements in the management of patients with ESRD, we aimed to better understand how Canadian nephrologists consider prognosis during routine care.
Design and Methods: A web-based multiple choice survey was designed, and administered to adult nephrologists in Canada through the e-mail list of the Canadian Society of Nephrology. The survey asked the respondents about their routine practice of estimating survival and the perceived importance of prognostic practices and tools in patients with ESRD. Descriptive statistics were used in analyzing the responses.
Results: Less than half of the respondents indicated they always or often make an explicit attempt to estimate and/or discuss survival with ESRD patients not on dialysis, and 25% reported they do so always or often with patients on dialysis. Survival estimation is most frequently based on clinical gestalt. Respondents endorse a wide range of issues that may be influenced by prognosis, including advance care planning, transplant referral, choice of dialysis access, medication management, and consideration of conservative care.
Limitations: This is a Canadian sample of self-reported behavior, which was not validated, and may be less generalizable to non-Canadian health care jurisdictions.
Conclusions: In conclusion, prognostication of patients with ESRD is an important issue for nephrologists and impacts management in fairly sophisticated ways. Information sharing on prognosis may be suboptimal.
Competing Interests: Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Databáze: MEDLINE